Indirect evidence of subclinical inflammation was found in the Framingham study, where higher spontaneous production of IL-1 or TNFα (AD markers in older individuals) by peripheral blood mononuclear cells was observed and defined as subclinical inflammation [61]. The gene discussed is IL1B; the disease is Alzheimer disease.